Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM
Konjac-Mannan (Glucomannan) Improves Glycemia and Other Associated Risk Factors for Coronary Heart Disease in Type 2 Diabetes
1 other identifier
interventional
11
0 countries
N/A
Brief Summary
To examine whether Konjac-mannan fiber improves metabolic control measured by glycemia, lipidemia, and blood pressure in individuals with type-2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jan 1991
Longer than P75 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1991
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 1992
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 1998
CompletedFirst Submitted
Initial submission to the registry
November 7, 2018
CompletedFirst Posted
Study publicly available on registry
November 15, 2018
CompletedNovember 15, 2018
November 1, 2018
1.4 years
November 7, 2018
November 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
change in total:HDL cholesterol
change from baseline at week 3, relative to control
change in fructosamine
change from baseline at week 3, relative to control
change in systolic blood pressure
change from baseline at week 3, relative to control
Secondary Outcomes (10)
change in total cholesterol
change from baseline at week 3, relative to control
change in LDL cholesterol
change from baseline at week 3, relative to control
change in HDL cholesterol
change from baseline at week 3, relative to control
change in apolipoprotein A-1
change from baseline at week 3, relative to control
change in apolipoprotain B
change from baseline at week 3, relative to control
- +5 more secondary outcomes
Study Arms (2)
Konjac-mannan
EXPERIMENTALKonjac-mannan fiber-enriched biscuits with NCEP Step II metabolically controlled diet
Placebo
PLACEBO COMPARATORwheat bran fiber biscuits with NCEP Step II metabolically controlled diet
Interventions
Konjac-mannan fiber-enriched biscuits (0.7 g/412KJ \[100kcal\] of glucommanan)
Eligibility Criteria
You may qualify if:
- hyperlipidemia controlled by medication
- hypertension controlled by medication
- type 2 diabetes controlled by medication
- minimum 3 years since onset of all three conditions
- sedentary lifestyle
You may not qualify if:
- regular smoking
- regular alcohol consumption
- family history of premature coronary heart disease
- hypothyroidism
- renal, hepatic or gastrointestinal disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- Dicofarmcollaborator
- University of Torontocollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2018
First Posted
November 15, 2018
Study Start
January 1, 1991
Primary Completion
June 1, 1992
Study Completion
June 1, 1998
Last Updated
November 15, 2018
Record last verified: 2018-11